Spectral Computed Tomography Market Analysis, Size, Share and Forecast, 2013-2023

Spectral computed tomography (CT) is a scanning device that is used for medical imaging for diagnosis in case of cancer, tumor development, cardiovascular impairment, aneurysm and other bone related disorders. Spectral CT has been considered as the next phase of the widely accepted computed tomography (CT) providing an effective imaging modality. The computed tomography reconstructs an object's internal structure, from a sequence of X-ray transmission images. Computed tomography functions by detecting the number of photons that hits the detector and attenuation in relation to the photons emitted by the X-ray tube that does not interact with the body. However, these detectors do not differentiate among the varied frequencies of the photons and provide monochromatic reconstructed image. These limitations of conventional CT support the development of spectral CT, leading to an increase in the growth of the overall spectral CT market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/spectral-computed-tomography

The novel spectral CT is based on dual energy, that measures both low and high energy photons during the absorption and scattering of X-rays, resulting into the formation of different energy bands. The body tissues absorb energy bands differently and hence any changes observed in these energy bands help in diagnosis of changes within the body. Spectral CT forms spectral base images and improves visualization of these constructs. This has been accepted by radiologists and clinicians for diagnosis throughout the medical industry by helping them investigate not only anatomy visualization but also tissue characterization.

The spectral CT market size is expected to grow significantly during the forecast period. The major factor driving this growth include the preference for spectral CT over conventional CT, since spectral CT offers comprehensive application base and constructs superior spectral derived images. Moreover, with the growing geriatric population, there has been increase in number of age-related disease. Additionally, unhealthy lifestyle has also led to an increased prevalence of chronic diseases. All the aforementioned factors are expected to drive the growth of the global market. Further, research in the field of unknown and rare diseases demand higher imaging and resolution techniques that are expected to favor the growing market of spectral CT.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/spectral-computed-tomography/report-sample

The key players across the globe, are launching products to gain a leading position in the spectral CT market share.

In February 2017, GE Healthcare announced the FDA approval of its GSI Xtream on Revolution CT, first of the volume spectral CT technology, that claims improved detection, tissue characterization and metal artifact reduction, with ease in operation.

In November 2014, Siemens Healthcare GmbH received USFDA clearance on its Siemens' syngo.CT Single Source Dual Energy software package, enabling spectral imaging using single source CT scanner.

The other players in the spectral CT market are Hitachi medical corporation, NeuroLogica Corp, Neusoft Medical Systems, Shenzhen Anke High-tech Co., Ltd.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.